MetaADEDB 2.0 @ LMMD
Tobramycin
(ZEUUPKVZFKBXPW-TWDWGCDDSA-N)
Structure
SMILES
OS(=O)(=O)O.NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@H]([C@@H]([C@H]2O)O[C@H]2O[C@H](CO)[C@H]([C@@H]([C@H]2O)N)O)N)[C@@H](C[C@@H]1O)N
Molecular Formula:
C18H39N5O13S
Molecular Weight:
565.593
Log P:
-2.3663
Hydrogen Bond Acceptor:
18
Hydrogen Bond Donor:
12
TPSA:
351.15
CAS Number(s):
49842-07-1; 79645-27-5
Synonym(s)
1.
Tobramycin
2.
Nebramycin Factor 6
3.
Brulamycin
4.
Nebcin
5.
Nebicin
6.
Obracin
7.
Tobracin
8.
Tobramycin Sulfate
9.
Sulfate, Tobramycin
External Link(s)
MeSHD014031
PubChem Compound62005
CHEMBLCHEMBL1200780
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1BotulismFAERS: 1US FAERS
2Burning sensationFAERS: 1US FAERS
3Dacryostenosis acquiredFAERS: 1US FAERS
4Deafness NeurosensoryFAERS: 1US FAERS
5DiplopiaFAERS: 1US FAERS
6Extra dose administeredFAERS: 1US FAERS
7Impaired work abilityFAERS: 1US FAERS
8Incorrect route of drug administrationFAERS: 1US FAERS
9Lip swellingFAERS: 1US FAERS
10Muscle strainFAERS: 1US FAERS
11PruritusFAERS: 1US FAERS
12Pseudo-Bartter syndromeFAERS: 1US FAERS
13Toxicity to various agentsFAERS: 1US FAERS
14UrticariaFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120242

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.